ARTICLE | Financial News
rEVO Biologics proposes IPO
June 30, 2014 7:00 AM UTC
rEVO Biologics Inc., Framingham, Mass. Business: Hematology Date announced:2014-06-25 Type: IPO To be raised: Up to $74.8 million Shares: TBD Price: TBD Underwriters: Piper Jaffray; Guggenheim Securit...